Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa arizona
  4. patient program management
Show results for
Products
Services
Software

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Arizona
Brands

  • decisiondx
  • decisiondx-um
  • mypath and diffdx
  • tissuecypher

Patient Program Management Equipment Supplied In Usa Arizona

4 equipment items found
In ArizonaAvailable In ArizonaNear Arizona

TissueCypher - Technology

TissueCypher - Technology

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Our platform combines a unique approach to bring together all the key elements of biologically aware artificial intelligence (AI) to deliver the spatialomics revolution to the clinician and enable individualized, patient-centric ...
CONTACT SUPPLIER

myPath and DiffDx - Melanoma Gene Expression Profile (GEP) Tests

myPath and DiffDx - Melanoma Gene Expression Profile (GEP) Tests

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Increased Clarity for Difficult-to-Diagnose Melanocytic Lesions. MyPath Melanoma and DecisionDx DiffDx Melanoma gene expression profile (GEP) tests are designed to provide objective information to aid in the diagnosis and inform management decisions for patients with ambiguous melanocytic ...
CONTACT SUPPLIER

DecisionDx-UM - Standard of Care for Predicting Metastatic Risk in Uveal Melanoma

DecisionDx-UM - Standard of Care for Predicting Metastatic Risk in Uveal Melanoma

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. However, within five years, approximately 30% of patients will develop metastasis – rising to nearly 50% in the following ...
CONTACT SUPPLIER

DecisionDx - Melanoma

DecisionDx - Melanoma

by:Castle Biosciences, Inc.   based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Recurrence or Metastasis: DecisionDx-Melanoma was designed to address the need for a more accurate predictor of metastatic risk in patients diagnosed with cutaneous (skin) melanoma. ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT